Dr. Brian Ballios is a Boston, Massachusetts based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Brian Ballios is 283016 in Massachusetts. Dr. Brian Ballios is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Brian Ballios speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD, PHD
Gender:
Male
Practice Address:
243 Charles St Rm 319, Boston, Massachusetts, 02114-3002
Phone:
617-573-3621
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1447869839
NPI Enumeration Date:
30 Jul, 2020
NPI Last Update On:
17 Aug, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Brian Ballios are as mentioned below.
License Number
Specialization
State
Status
283016
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8 Whittier Pl Apt 21a, Boston, Massachusetts
Zip:
02114-1426
Phone Number:
617-510-8752
Fax Number:
--
Patients can reach Dr. Brian Ballios at 243 Charles St Rm 319, Boston, Massachusetts or can call to book an appointment on 617-573-3621. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.